NEW YORK (GenomeWeb) – OpGen after the close of the market Wednesday reported a 128 percent increase in its first quarter revenues.

For the three months ended March 31, the Gaithersburg, Maryland-based infectious disease testing and bioinformatics firm reported revenues of $1.1 million, up from $472,200 in the first quarter of 2015. The rise is attributable to sales of AdvanDx diagnostic products and CLIA laboratory services provided using the Acuitas multi-drug resistant organisms testing suite, OpGen Chairman and CEO Evan Jones said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.